Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 273

Related Articles by Review for PubMed (Select 14996343)

1.
2.

Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.

Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M.

Eur J Gastroenterol Hepatol. 2008 Apr;20(4):320-6. doi: 10.1097/MEG.0b013e3282f340c8. Review.

PMID:
18334876
3.

Management of chronic hepatitis B.

Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.

4.

Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B.

Hui CK, Lau GK.

Expert Rev Anti Infect Ther. 2005 Aug;3(4):495-504. Review.

PMID:
16107195
5.

Hepatitis B.

Lin KW, Kirchner JT.

Am Fam Physician. 2004 Jan 1;69(1):75-82. Review. Erratum in: Am Fam Physician. 2004 Apr 15;69(8):1863.

6.

Hepatitis B--an important public health issue.

Maddrey WC.

Clin Lab. 2001;47(1-2):51-5. Review.

PMID:
11214223
7.

Therapeutic management of hepatitis B-related cirrhosis.

Merle P, Trepo C.

J Viral Hepat. 2001 Nov;8(6):391-9. Review.

PMID:
11703569
8.

Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

Rivkin A.

Drugs Today (Barc). 2007 Apr;43(4):201-20. Review.

PMID:
17460784
9.

Hepatitis B in children.

Broderick AL, Jonas MM.

Semin Liver Dis. 2003 Feb;23(1):59-68. Review.

PMID:
12616451
10.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
11.

Treatment of chronic hepatitis B infection: an update of Swedish recommendations.

Lindh M, Uhnoo I, Bläckberg J, Duberg AS, Friman S, Fischler B, Karlström O, Norkrans G, Reichard O, Sangfeldt P, Söderström A, Sönnerborg A, Weiland O, Wejstål R, Wiström J.

Scand J Infect Dis. 2008;40(6-7):436-50. doi: 10.1080/00365540802154769. Review.

PMID:
18584530
12.
13.

Peginterferon-alpha 2a for the treatment of hepatitis B infection.

Cooksley WG.

Expert Opin Pharmacother. 2005 Jul;6(8):1373-80. Review.

PMID:
16013986
14.

Treatment of chronic hepatitis B.

Cornberg M, Jaroszewicz J, Manns MP, Wedemeyer H.

Minerva Gastroenterol Dietol. 2010 Dec;56(4):451-65. Review.

PMID:
21139543
15.

Current pharmacotherapy for hepatitis B infection.

Galan MV, Boyce D, Gordon SC.

Expert Opin Pharmacother. 2001 Aug;2(8):1289-98. Review.

PMID:
11584997
16.

New and emerging treatment of chronic hepatitis B.

Keeffe EB, Marcellin P.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):285-94. Epub 2007 Jan 9. Review.

PMID:
17218162
17.

Treatment of hepatitis B with interferon and combination therapy.

Cooksley WG.

Clin Liver Dis. 2004 May;8(2):353-70. Review.

PMID:
15481344
18.

Hepatitis B: an important public health issue.

Maddrey WC.

J Med Virol. 2000 Jul;61(3):362-6. Review.

PMID:
10861647
19.

Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention.

Lavanchy D.

J Clin Virol. 2005 Dec;34 Suppl 1:S1-3. Review.

PMID:
16461208
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk